期刊文献+

Identification of compound heterozygous mutations in the ITGA2B gene in a Chinese patient with Glanzmann thrombasthenia

Identification of compound heterozygous mutations in the ITGA2B gene in a Chinese patient with Glanzmann thrombasthenia
原文传递
导出
摘要 Background Glanzmann thrombasthenia (GT) is an autosomal recessive bleeding disorder characterized by the tendency to hemorrhage and the inability of platelets to aggregate in response to agonists. GT is caused by a defect of the platelet glycoprotein lib/Ilia complex. The objective of this study was to describe the clinical features and the genetic cause of GT in a 6-year-old girl from south China. Methods A three-generation family was studied. The proband patient aged 6 years and her parents undertook examinations of platelet counts, blood film, bleeding time, platelet aggregation, and flow cytometry. All coding exons of the ITGA2B and ITGB3 genes were amplified by polymerase chain reaction (PCR), and direct sequencing was performed for mutational screening on the patient and normal controls consisted of 52 healthy blood donors. Reverse transcription PCR was conducted to test for exon skipping. Results The proposita patient showed dispersing platelets, prolonged bleeding time, and severely reduced platelet aggregation in response to the physiological agonists adenosine diphosphate (ADP), epinephrine, collagen, and ristocetin. Flow cytometric measurements showed that the contents of allb and 133 were significantly decreased. Sequencing results demonstrated two different types of heterozygous mutations existed in the allb gene (c.2930delG and IVS15-1delG). The compound mutations were also confirmed in the patient's mother and father separately. Conclusions The allbβ3 deficiency of the proband was caused by two compound ITGA2B mutations, which were first reported in Chinese GT patients. The IVS15-1delG was first confirmed to cause an exon skipping. Background Glanzmann thrombasthenia (GT) is an autosomal recessive bleeding disorder characterized by the tendency to hemorrhage and the inability of platelets to aggregate in response to agonists. GT is caused by a defect of the platelet glycoprotein lib/Ilia complex. The objective of this study was to describe the clinical features and the genetic cause of GT in a 6-year-old girl from south China. Methods A three-generation family was studied. The proband patient aged 6 years and her parents undertook examinations of platelet counts, blood film, bleeding time, platelet aggregation, and flow cytometry. All coding exons of the ITGA2B and ITGB3 genes were amplified by polymerase chain reaction (PCR), and direct sequencing was performed for mutational screening on the patient and normal controls consisted of 52 healthy blood donors. Reverse transcription PCR was conducted to test for exon skipping. Results The proposita patient showed dispersing platelets, prolonged bleeding time, and severely reduced platelet aggregation in response to the physiological agonists adenosine diphosphate (ADP), epinephrine, collagen, and ristocetin. Flow cytometric measurements showed that the contents of allb and 133 were significantly decreased. Sequencing results demonstrated two different types of heterozygous mutations existed in the allb gene (c.2930delG and IVS15-1delG). The compound mutations were also confirmed in the patient's mother and father separately. Conclusions The allbβ3 deficiency of the proband was caused by two compound ITGA2B mutations, which were first reported in Chinese GT patients. The IVS15-1delG was first confirmed to cause an exon skipping.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2010年第11期1397-1401,共5页 中华医学杂志(英文版)
关键词 Glanzmann thrombasthenia integrin alIIbβ mutation exon skipping HEMORRHAGE Glanzmann thrombasthenia integrin alIIbβ mutation, exon skipping hemorrhage
  • 相关文献

参考文献4

二级参考文献32

  • 1Fullard JF. The role of the platelet glycoprotein Ⅱ b/Ⅲ a in thrombosis and haemostasis. Curr Pharm Des ,2004,10 : 1567-1576. 被引量:1
  • 2Nair S, Ghosh K, Kulkami B, et al. Glanzmann' s thrombasthenia : updated. Platelets,2002,13:387-393. 被引量:1
  • 3Michelson AD. Flow cytometry:a clinical test of platelet function.Blood, 1996,87:4925-4936. 被引量:1
  • 4Uzan G,Frachet P,Lajmanovich A,et al. cDNA clones for human platelet GP Ⅱ b corresponding to mRNA from megakaryocytes and HEL cells. Evidence for an extensive homology to other Arg-Gly- Asp adhesion receptors. Eur J Biochem, 1988,171:87-93. 被引量:1
  • 5D' Andrea G, Colaizzo D, Vecchione G, et al. Glanzmann ' thrombasthenia: identification of 19 new mutations in 30 patients. Thromb Haemost ,2002,87 : 1034-1042. 被引量:1
  • 6Boudreaus MK, Lipscomb DL. Clinical, biochemical, and molecular aspects of Glanzmann' s thrombasthenia in humans and dogs. Vet Pathol, 2001,38 : 249 -260. 被引量:1
  • 7Peretz H, Rosenberq N, Landau M, et al. Molecular diversity of Glanzmann thrombasthenia in southern India: new insights into mRNA splicing and structure-function correlations of alphaIIbbeta3 integrin( ITGA2B, ITGB3 ) . Hum Murat ,2006,27:359-369. 被引量:1
  • 8Shattil SJ, Kashiwagi H, Pampori N, et al. Integrin signaling: the plateletparadigm. Blood, 1998,91 : 2645-2657. 被引量:1
  • 9Nurden AT. Glanzmann thrombasthenia. Orphanet J Rare Dis, 2006,1: 10. 被引量:1
  • 10Fullard JF. The role of the platelet glycoprotein Ⅱ b/Ⅲ a in thrombosis and haemostasis. Curr Pharm Des, 2004, 10: 1567-1576. 被引量:1

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部